Medtech company goes public without FDA product approval
- Posted on December 16, 2024
- By Star Tribune
- 3 Views
Medtech company goes public without FDA product approval
Anteris is developing a transcatheter heart valve called DurAVR with a single piece of bioengineered tissue to treat aortic stenosis
